NEOVACS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.29 EUR | -6.42% |
|
-21.62% | -85.50% |
| 1 week | -21.62% | ||
| Current month | -56.70% |
| Sales 2021 | 22.54K 24.1K | Sales 2022 | 1.11K 1.19K | Capitalization | 102K 109K |
|---|---|---|---|---|---|
| Net income 2021 | -11M -11.76M | Net income 2022 | -3M -3.21M | EV / Sales 2021 | - |
| Net cash position 2021 | 32.06M 34.27M | Net cash position 2022 | 5.55M 5.94M | EV / Sales 2022 | - |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | 23 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0.12% |
More Fundamentals
* Assessed data
More news
| 1 day | -6.42% | ||
| 1 week | -21.62% | ||
| Current month | -56.70% | ||
| 1 month | -58.57% | ||
| 3 months | -85.50% | ||
| 6 months | -85.50% | ||
| Current year | -85.50% |
1 week
0.29
0.37
1 month
0.290.69
Current year
0.293.20
1 year
0.2932 000.00
3 years
0.291 000 000.00
5 years
0.291 000 000.00
10 years
0.291 000 000.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.29 | -6.42% | 8,616 |
| 24-04-25 | 0.3099 | +6.83% | 1,239 |
| 24-04-24 | 0.2901 | -3.30% | 7,992 |
| 24-04-23 | 0.3 | -11.50% | 30,035 |
| 24-04-22 | 0.339 | -8.38% | 7,988 |
Real-time Euronext Paris, April 26, 2024 at 11:22 am EDT
More quotes
NEOVACS has become a major player in the therapeutic vaccines for the treatment of autoimmune and / or inflammatory diseases. With its innovative technology inducing a polyclonal immune response, protected by four patent families potentially until 2038, NEOVACS focuses its clinical efforts on the development of IFN?-Kinoid for treating lupus. The group also carries out preclinical work on other therapeutic vaccines to treat autoimmune diseases, cancer, allergies and type 1 diabetes.
| 1st Jan change | Capi. | |
|---|---|---|
| -85.50% | 109K | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- ALNEV Stock
